Kaili Mao

1.5k total citations
50 papers, 1.2k citations indexed

About

Kaili Mao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomaterials. According to data from OpenAlex, Kaili Mao has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Biomaterials. Recurrent topics in Kaili Mao's work include Nanoparticle-Based Drug Delivery (8 papers), Prostate Cancer Treatment and Research (7 papers) and Angiogenesis and VEGF in Cancer (5 papers). Kaili Mao is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Prostate Cancer Treatment and Research (7 papers) and Angiogenesis and VEGF in Cancer (5 papers). Kaili Mao collaborates with scholars based in China, France and United States. Kaili Mao's co-authors include Ying‐Zheng Zhao, Cui‐Tao Lu, Baolin Zhang, Yinping Huang, Furong Tian, Ho Lun Wong, Zi-Liang Fan, Pian-Pian Chen, Jian Xiao and Jingjing Yang and has published in prestigious journals such as PLoS ONE, Biomaterials and The Science of The Total Environment.

In The Last Decade

Kaili Mao

41 papers receiving 1.2k citations

Peers

Kaili Mao

BIOMA

PRM

Xu-Qi Kang China

Jia Guo China

Wei Fan China

David Y.B. Deng China

Da Yeon Kim South Korea

Gloria Perazzoli Spain

Zibin Gao China

Kayvan Sadri Iran

ChangJu Chun South Korea

Raffaele Ferrari Italy

Xu-Qi Kang China

Kaili Mao

271 ×0.7

BIOMA

304 ×0.9

336 ×1.0

78 ×0.5

117 ×0.8

PRM

Citations per year, relative to Kaili Mao Kaili Mao (= 1×) peers Xu-Qi Kang

Countries citing papers authored by Kaili Mao

Since Specialization

Citations

This map shows the geographic impact of Kaili Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaili Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaili Mao more than expected).

Fields of papers citing papers by Kaili Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaili Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaili Mao. The network helps show where Kaili Mao may publish in the future.

Co-authorship network of co-authors of Kaili Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Kaili Mao. A scholar is included among the top collaborators of Kaili Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaili Mao. Kaili Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Bo, Liying Chen, Yan Hu, et al.. (2025). A retrospective analysis of small molecule targeting inhibitor usage for lung cancer among outpatients in six major regions of China (2016–2022). Frontiers in Pharmacology. 16. 1700389–1700389.

Xu, Feng, et al.. (2025). Antithrombotic management in an elderly CABG patient with nephrotic syndrome: a case report. Frontiers in Cardiovascular Medicine. 12. 1595027–1595027.

Gao, Qian, Weijun Wang, Shujuan Sun, et al.. (2025). Bundling gold nanorods with RCA-produced DNA tape into an intelligently reconfigurable nanocluster bomb for multimodal precision cancer therapy. Materials Today Bio. 32. 101718–101718. 2 indexed citations

Xu, Feng, et al.. (2025). Bleeding in Antiplatelet Therapy: A Narrative Review of Clinical Evidence and the Roles of Pharmacists and Nurses. Reviews in Cardiovascular Medicine. 26(11). 45077–45077.

Jin, Lei, Guoquan Chen, Jun Xie, et al.. (2025). Real-World Safety of Anti-EGFR Antibodies: 20-Year Pharmacovigilance of Cetuximab and Panitumumab. International Journal of Medical Sciences. 22(15). 4131–4144. 1 indexed citations

Li, Liucheng, et al.. (2025). Unraveling the role of FGF7 in osteoarthritis and osteoporosis: Therapeutic implications and challenges. The FASEB Journal. 39(6). e70479–e70479.

Mao, Kaili, et al.. (2024). Presence of 1, 3-diphenylguanidine and its derivatives in human urine and their human exposure. Environmental Research. 263(Pt 3). 120252–120252. 1 indexed citations

Mao, Weili, et al.. (2024). Presence of carbazole and polyhalogenated carbazoles in human urine. The Science of The Total Environment. 923. 171609–171609. 5 indexed citations

Mao, Kaili, et al.. (2024). Ocular adverse events associated with antibody-drug conjugates in oncology: a pharmacovigilance study based on FDA adverse event reporting system (FAERS). Frontiers in Pharmacology. 15. 1425617–1425617. 10 indexed citations

10.

Mao, Weili, et al.. (2023). Associations between urinary parabens and lung cancer. Environmental Science and Pollution Research. 30(24). 66186–66194. 8 indexed citations

11.

Mao, Kaili, et al.. (2023). Ultra-small micelles together with UTMD enhanced the therapeutic effect of docetaxel on Glioblastoma. European Journal of Pharmaceutical Sciences. 187. 106468–106468. 4 indexed citations

12.

Mao, Weili, et al.. (2023). Efficacy and safety of Danlou tablets in traditional Chinese medicine for coronary heart disease: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 10. 1100006–1100006. 4 indexed citations

13.

Mao, Weili, et al.. (2022). A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors. Frontiers in Public Health. 10. 969070–969070. 7 indexed citations

14.

Zhao, Ying‐Zheng, Min Lin, Qian Lin, et al.. (2016). Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model. Journal of Controlled Release. 224. 165–175. 85 indexed citations

15.

Xu, Helin, Kaili Mao, Cui‐Tao Lu, et al.. (2016). An injectable acellular matrix scaffold with absorbable permeable nanoparticles improves the therapeutic effects of docetaxel on glioblastoma. Biomaterials. 107. 44–60. 43 indexed citations

16.

Zhao, Ying‐Zheng, Rongrong Jin, Wei Yang, et al.. (2016). Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats. PLoS ONE. 11(2). e0148848–e0148848. 42 indexed citations

17.

Zhao, Ying‐Zheng, Kaili Mao, Furong Tian, et al.. (2015). Gelatin nanoparticle-mediated intranasal delivery of substance P protects against 6-hydroxydopamine-induced apoptosis: an in vitro and in vivo study. Drug Design Development and Therapy. 9. 1955–1955. 13 indexed citations

18.

Chen, Weihua, Nicolas Barry Delongchamps, Kaili Mao, et al.. (2015). High RhoA expression at the tumor front in clinically localized prostate cancer and association with poor tumor differentiation. Oncology Letters. 11(2). 1375–1381. 13 indexed citations

19.

Zhao, Ying‐Zheng, Xi Jiang, Jian Xiao, et al.. (2015). Using NGF heparin-poloxamer thermosensitive hydrogels to enhance the nerve regeneration for spinal cord injury. Acta Biomaterialia. 29. 71–80. 105 indexed citations

20.

Chen, Weihua, Kaili Mao, T. Hua-Huy, et al.. (2014). Fasudil inhibits prostate cancer-induced angiogenesis in vitro. Oncology Reports. 32(6). 2795–2802. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact